| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novocure Limited (NVCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. NVCR is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 437.6K | $5.96M | - | |
| Dir | 416.5K | $5.67M | - | |
| VP | 347.7K | $4.73M | - | |
| Other | 174.5K | $2.37M | - | |
| Other | 163.8K | $2.23M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Burke William Patrick62 | Chief Human Resources Officer | Sell | 281 | $75.28 | $21,153.09 | -0.4% | -4.4% | -78.4% | |
| Mar 2, 2023 | Leonard Frank X76 | President, Cns Cancers Us | Sell | 4,107 | $75.38 | $309,577.72 | -3.4% | -4.4% | -78.4% | |
| Mar 1, 2023 | Leonard Frank X76 | President, Cns Cancers Us | Sell | 1,684 | $76.36 | $128,594.28 | -2.6% | -6.9% | -79.9% | |
| Mar 1, 2023 | Shah Pritesh75 | Chief Growth Officer | Sell | 1,923 | $76.36 | $146,844.90 | -1.9% | -6.9% | -79.9% | |
| Mar 1, 2023 | Cordova Ashley75 | Chief Financial Officer | Sell | 2,198 | $76.36 | $167,844.56 | -2.2% | -6.9% | -79.9% | |
| Mar 1, 2023 | Burke William Patrick62 | Chief Human Resources Officer | Sell | 755 | $76.36 | $57,653.61 | -1.1% | -6.9% | -79.9% | |
| Mar 1, 2023 | Groenhuysen Wilhelmus Cm65 | Chief Operating Officer | Sell | 2,164 | $76.36 | $165,248.23 | -1.2% | -6.9% | -79.9% | |
| Jan 5, 2023 | Weinberg Uri72 | Chief Science Officer | Sale+OE | 8,143 | $116.14 | $945,756.00 | -4.3% | -47.7% | -88.8% | |
| Jan 5, 2023 | Leonard Frank X76 | President, Cns Cancers Us | Sale+OE | 39,507 | $112.25 | $4,434,654.08 | -8.6% | -47.7% | -88.8% | |
| Jan 5, 2023 | Shah Pritesh75 | Chief Commercial Officer | Sell | 387 | $108.00 | $41,796.00 | -0.5% | -47.7% | -88.8% |